Iradimed (IRMD) Dividends payables (2023)

Iradimed (IRMD) reported Dividends payables of $8.0 million for Q4 2023.

Iradimed (IRMD) Dividends payables (2023) Analysis & Trends

Iradimed (IRMD) has 1 years of Dividends payables data on file, last reported at $8.0 million in Q4 2023.

  • Dividends payables for Q4 2023 came in at $8.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $8.0 million (changed N/A YoY), and the FY2023 annual result was $8.0 million, changed N/A from the prior year.
  • Dividends payables was little changed at $8.0 million in Q4 2023 per IRMD's latest filing.
  • Over five years, Dividends payables peaked at $8.0 million in Q4 2023 and troughed at $8.0 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.10 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 337.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Iradimed 1.18 Bn 1.12 Bn 16.81 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 7.98 Mn